APA

Laidlaw K. M. E., Berhan S., Liu S., Silvestri G., Holyoake T. L., Frank D. A., Aggarwal B., Bonner M. Y., Perrotti D., Jørgensen H. G. & Arbiser J. L. (20180206). Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia. : Oncotarget.

Chicago

Laidlaw Kamilla M E, Berhan Samuel, Liu Suhu, Silvestri Giovannino, Holyoake Tessa L, Frank David A, Aggarwal Bharat, Bonner Michael Y, Perrotti Danilo, Jørgensen Heather G and Arbiser Jack L. 20180206. Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia. : Oncotarget.

Harvard

Laidlaw K. M. E., Berhan S., Liu S., Silvestri G., Holyoake T. L., Frank D. A., Aggarwal B., Bonner M. Y., Perrotti D., Jørgensen H. G. and Arbiser J. L. (20180206). Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia. : Oncotarget.

MLA

Laidlaw Kamilla M E, Berhan Samuel, Liu Suhu, Silvestri Giovannino, Holyoake Tessa L, Frank David A, Aggarwal Bharat, Bonner Michael Y, Perrotti Danilo, Jørgensen Heather G and Arbiser Jack L. Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia. : Oncotarget. 20180206.